購読する
モデル製品
サービス
前臨床薬効評価
コミュ二ティー
B6-hFCGR1 Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
B6-hFCGR1 Mouse
製品名
B6-hFCGR1 Mouse
製品ID
C001500
系統名
C57BL/6NCya-Fcgr1tm1(hFCGR1A)/Cya
背景情報
C57BL/6NCya
状況
このマウス系統を論文で使用する場合は、「B6-hFCGR1 Mouse(カタログ番号C001500)はサイアジェンから購入しました。」と引用してください。
HUGO-GT Humanized Models
Immune Target Humanized Mouse Models
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
HUGO-GT Humanized Models
Immune Target Humanized Mouse Models
基本情報
検証 Data
関連リソース
基本情報
系統詳細
FCGR1 gene encodes FcγRI, a specific receptor for IgG antibodies, also known as CD64. This receptor plays a key role in human immune responses. FcγRI has a high affinity for the Fc portion of IgG antibodies and is the only member of the human FcγRs with a high affinity for monomeric IgG. It plays important roles in both innate and adaptive immune responses [1]. FcγRI is expressed on a variety of immune cells, including monocytes, macrophages, dendritic cells, and neutrophils. It plays a critical role in host defense against infection and humoral immunity by influencing processes such as phagocytosis, antibody-dependent cell-mediated cytotoxicity (ADCC), and antigen presentation [2-3]. The binding of FcγRI to IgG-coated target cells promotes their phagocytosis by immune cells. This is an important mechanism for clearing infected cells, apoptotic cells, and other foreign particles. In addition, this binding can also promote the release of cytotoxic granules by immune cells, such as natural killer cells and cytotoxic T cells, leading to the killing and lysis of target cells. In antigen presentation, FcγRI binding to IgG-coated antigens promotes dendritic cells to take them up and present them to T cells, which is essential for the initiation of adaptive immune responses. In addition, FcγRI is involved in a variety of important physiological processes, such as wound healing and inflammation. FcγRI plays a critical role in antibody-based immunotherapy, which has important implications for the development of therapeutic drugs and methods for a variety of autoimmune diseases, infectious diseases, and tumors [4-5].
This model represents a humanized FCGR1 mouse, generated by substituting the mouse Fcgr1 gene sequence (inclusive of the UTR) with the corresponding human FCGR1 gene sequence. This modification enables the expression of human FcγRI in mice. Homozygous B6-hFCGR1 mice exclusively express human FcγRI receptors, with the proportion of cells expressing human FcγRI mirroring that of cells expressing mouse FcγRI in wild-type mice. Consequently, this model serves as a valuable tool for various research areas, including the evaluation of human IgG antibody affinity, exploration of the ADCC mechanism, investigation into immune cell phagocytosis and antigen presentation. Furthermore, it provides a platform for the preclinical assessment of therapeutic human IgG antibodies.
参考文献
van der Poel CE, Spaapen RM, van de Winkel JG, Leusen JH. Functional characteristics of the high affinity IgG receptor, FcγRI. J Immunol. 2011 Mar 1;186(5):2699-704.
Lu J, Chu J, Zou Z, Hamacher NB, Rixon MW, Sun PD. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding. Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):833-8.
Junker F, Gordon J, Qureshi O. Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Front Immunol. 2020 Jul 3;11:1393.
Hogarth PM, Pietersz GA. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov. 2012 Mar 30;11(4):311-31.
Holtrop T, Budding K, Brandsma AM, Leusen JHW. Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer. Immunother Adv. 2022 May 28;2(1):ltac011.
系統作製戦略
The mouse Fcgr1 gene sequence was completely replaced with the corresponding sequence in the human FCGR1A gene by gene editing technology.

Figure 1. Diagram of the gene editing strategy for the generation of B6-hFCGR1 mice.
適用分野
Studies of antibody-dependent cell-mediated cytotoxic effects (ADCC);
Phagocytosis and antigen presentation studies of the immune system;
Drug affinity, pharmacology, and efficacy assessment based on FcγRI receptor IgG antibodies.
検証 Data
関連リソース
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
